Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine sarcomas: a clinicopathologic study, 1965-1981.

M J Marchese, A S Liskow, C P Crum

    Gynecologic Oncology
    |July 1, 1984
    PubMed
    Summary

    Uterine sarcoma survival rates were 55% at 2 years and 27% at 5 years. Complete surgical resection and adjuvant chemotherapy significantly improved outcomes for uterine sarcoma patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Iron addiction: a novel therapeutic target in ovarian cancer.

    Oncogene·2017
    Same author

    Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center.

    Gynecologic oncology·2015
    Same author

    Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.

    Oncogene·2009
    Same author

    Gross abnormalities of the umbilical cord: related placental histology and clinical significance.

    Placenta·2009
    Same author

    Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast.

    Placenta·2008
    Same author

    Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

    Histopathology·2008

    Area of Science:

    • Gynecologic Oncology
    • Surgical Pathology
    • Medical Oncology

    Background:

    • Uterine sarcomas are rare and aggressive malignancies.
    • Accurate diagnosis and prognostic factors are crucial for patient management.

    Purpose of the Study:

    • To analyze prognostic indicators and treatment outcomes for uterine sarcomas.
    • To evaluate the impact of surgical resection and adjuvant chemotherapy on survival.

    Main Methods:

    • Retrospective analysis of 46 uterine sarcoma cases diagnosed between 1965 and 1981.
    • Histopathological review, including mitotic count, for diagnosis and subtyping.
    • Actuarial survival rate calculation and comparison based on prognostic factors and treatment modalities.

    Main Results:

    • Overall 5-year actuarial survival for uterine sarcomas was 27%.
    • Stage and age were significant prognostic indicators.
    • Complete surgical resection was essential for long-term survival.
    • Adjuvant chemotherapy (VAC) demonstrated improved survival in resected patients (61% vs 15%).
    • Leiomyosarcoma patients had better survival than malignant mixed mesodermal patients, particularly when under 70.
    • Seventy percent of recurrences occurred within 2 years, with lung being the most common site.

    Conclusions:

    • Complete surgical resection is critical for uterine sarcoma management.
    • Adjuvant chemotherapy may improve survival, warranting further investigation.
    • Early detection and management of recurrences are important due to rapid progression.

    Related Experiment Videos